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Apoptosis of hepatic stellate cells: involvement in
resolution of biliary fibrosis and regulation by
soluble growth factors
R Issa, E Williams, N Trim, T Kendall, M J P Arthur, J Reichen, R C Benyon, J P Iredale
Abstract
Background—Activated hepatic stellate
cells (HSC) are central to the pathogen-
esis of liver fibrosis, both as a source of
fibrillar collagens that characterise fibro-
sis and matrix degrading metalloprotein-
ases and their tissue inhibitors, the
TIMPs.
Aims—To test the hypothesis that HSC
apoptosis is critical to recovery from
biliary fibrosis and that soluble growth
factors may regulate HSC survival and
apoptosis.
Methods—Rats (n=15) were subjected to
bile duct ligation for 21 days, after which
biliodigestive anastomosis was under-
taken (n=13). Livers were harvested at
fixed time points of recovery for periods of
up to 42 days. Numbers of activated HSCs
were quantified after á smooth muscle
actin staining and HSC apoptosis was
detected by terminal UDP-nick end label-
ling (TUNEL) staining and quantified at
each time point. HSC apoptosis was
quantified in vitro in the presence or
absence of insulin-like growth factor
(IGF)-1, IGF-2, platelet derived growth
factor (PDGF), and transforming growth
factor â1 (TGF-â1).
Results—Following biliodigestive anasto-
mosis after 21 days of bile duct ligation,
rat liver demonstrated a progressive reso-
lution of biliary fibrosis over 42 days,
associated with a fivefold decrease in acti-
vated HSC determined by á smooth mus-
cle actin staining. TUNEL staining
indicated that loss of activated HSC
resulted from an increase in the rate of
apoptosis during the first two days post
biliodigestive anastomosis. Serum depri-
vation and culture in the presence of
50 µM cycloheximide was associated with
an increase in HSC apoptosis which was
significantly inhibited by addition of 10
ng/ml and 100 ng/ml IGF-1, respectively
(0.05>p, n=5). In contrast, 1 and 10 ng/ml
of TGF-â1 caused a significant increase in
HSC apoptosis compared with serum free
controls (p<0.05, n=4). PDGF and IGF-2
were neutral with respect to their eVect on
HSC apoptosis.
Conclusion—HSC apoptosis plays a criti-
cal role in the spontaneous recovery from
biliary fibrosis. Both survival and apopto-
sis of HSC are regulated by growth factors
expressed during fibrotic liver injury.
(Gut 2001;48:548–557)
Keywords: hepatic stellate cells; apoptosis; hepatic
fibrosis; insulin-like growth factor; transforming
growth factor â1
Liver fibrosis represents the common end point
of the majority of chronic liver injuries.1 2 Ulti-
mately, it results in distortion of the liver archi-
tecture (cirrhosis) which is associated with dis-
turbance of liver function and significant
morbidity and mortality. At the cellular level
there is now a wealth of evidence indicating
that the hepatic stellate cell (HSC) represents
the pivot of the fibrotic process.1–3 During liver
injury, HSCs undergo transformation from a
retinoid rich pericyte-like cell to a
myofibroblast-like cell, a process termed acti-
vation.1 2 Highly activated HSCs are morpho-
logically indistinguishable from myofibrob-
lasts. The activated HSCs express collagen I
and other extracellular matrix genes and are
quantitatively the major source of the matrix
which accumulates during fibrosis.3 4 During
activation, HSC enter the cell cycle with the
result that the hepatic matrix accumulation is
the result of an overall increase in the number
of HSCs in addition to changes in HSC gene
expression.1–4
We have previously demonstrated that recov-
ery from relatively advanced CCl4 induced liver
fibrosis can occur in a reproducible manner.5
Recovery is associated with remodelling of the
excess liver matrix resulting in restitution of
near normal liver architecture. An essential
element of this recovery process is apoptosis of
activated HSCs.5 6 An understanding of the
control of HSC apoptosis is important pre-
cisely because regulating this process may pro-
vide a novel therapeutic approach to the treat-
ment of advanced hepatic fibrosis.5–7 As part of
our previous study we showed that HSCs
cultured from rat liver respond to absolute
serum deprivation by undergoing apoptosis,
indicating that activated HSCs undergo apop-
tosis as a default pathway, once the cell is
deprived of specific survival signals. In the cur-
rent study we have described the role of HSC
apoptosis in a mechanistically distinct model of
reversal of fibrosis (bile duct ligation followed
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stellate cell; IGF-1 (-2), insulin-like growth factor 1
(2); TGF-â1, transforming growth factor â1; PDGF,
platelet derived growth factor; BDL, bile duct ligation;
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by reanastomosis8 9) and have also character-
ised the response of activated HSCs to growth
factor deprivation in detail to determine the
potential roles of insulin-like growth factor
(IGF)-1, IGF-2, transforming growth factor â1
(TGF-â1), and platelet derived growth factor
(PDGF) in acting as survival factors for HSCs.
Our data support the hypotheses that HSC
apoptosis is a general response in the recovery
from fibrosis and that specific growth factors
and cytokines may regulate survival of HSCs.
Methods
BILE DUCT LIGATION AND ANASTOMOSIS
Bile duct ligation (BDL) was undertaken in 15
male Sprague-Dawley rats exactly as previously
described.9 After 21 days of BDL, 13 animals
underwent a further laparotomy at which a
Roux-en-Y choledochal-jejunostomy was per-
formed to eVect biliary drainage, as previously
described.9 At time points before and following
reanastomosis, groups of animals were killed
and the liver harvested, fixed in buVered
formalin, and blocked in paraYn. Livers were
harvested at 21 days post BDL (peak fibrosis,
n=2) and at one day (n=3), two days (n=4),
seven days (n=4), and 42 days (n=2) of recov-
ery post biliary-jejunal anastomosis. In addi-
tion, control livers subjected to a sham
operation (n=4) were harvested at 21 days and
included in the analysis described below.
HISTOLOGICAL ANALYSIS AND QUANTITATION OF
ACTIVATED HSC DURING RECOVERY FROM BDL
Blocks containing four lobes from each fixed
liver were sectioned and stained with haema-
toxylin and eosin, Sirius red, and reticulin.
Further sections were deparaYnised and sub-
jected to microwave antigen retrieval before
being stained for á smooth muscle actin
(á-SMA), as described previously.5 Afterwards,
the number of á-SMA positive cells were
counted in 50 random high power fields of each
of the four lobes—that is, the mean number of
activated HSCs per high power field was deter-
mined from 200 individual observations.
DETERMINATION OF NUMBERS OF
NON-PARENCHYMAL CELLS UNDERGOING
APOPTOSIS FOLLOWING BILIARY-JEJUNAL
ANASTOMOSIS
Sections of each model liver were stained for
DNA fragmentation characteristic of apoptosis
by the terminal UDP-nick end labelling
(TUNEL) reaction, as previously described,5
with the modifications recently described to
reduce false positivity.10 Each slide was then
analysed by a blinded observer who counted
the number of non-parenchymal TUNEL
positive apoptotic figures per 50 high power
field (×40) per liver lobe section—that is, the
mean number of apoptotic non-parenchymal
cells per high power field was determined from
200 observations. Apoptotic bodies in a distri-
bution consistent with hepatocytes were not
counted. Dual staining for á-SMA and
TUNEL was undertaken in representative liver
sections as previously described to localise
apoptosis to HSCs.5
HSC EXTRACTION AND CULTURE
HSCs were extracted from normal rat liver by
sequential in situ perfusion with pronase and
collagenase, as previously described.11 Cells
were seeded onto uncoated tissue culture plas-
tic in Dulbecco’s modified Eagle’s medium
(DMEM) with 16% fetal calf serum (FCS) and
grown for 10–14 days until a monolayer of
myofibroblast-like activated HSCs was ob-
tained. Cells were then trypsinised and re-
plated onto 24 well uncoated plastic and main-
tained in DMEM containing 16% FCS.
Experimental manipulations were performed
after passaging when cells had reached 80%
confluence.
QUANTIFICATION OF APOPTOSIS IN HSC CULTURE
Passaged HSCs were washed twice in serum
free media before being preincubated in serum
free media for one hour. Thereafter the media
from the preincubation was discarded and cells
were cultured for defined periods of time in
serum free DMEM containing 0.1% bovine
serum albumin. In each experiment parallel
cells were returned to culture in media supple-
mented with 16% FCS. The eVect of the spe-
cific growth factors on HSC survival was
determined by adding predetermined concen-
trations of each growth factor to pairs of wells
for periods of up to 24 hours. The growth fac-
tors studied were PDGF-AB (Sigma, Poole,
UK), IGF-1 and IGF-2 (Peprotech, London,
UK), and TGF-â1 (Sigma, Poole, UK). Cells
were also cultured in the presence of cyclohex-
imide (6.25–50 µM final concentration) in the
presence and absence of 16% FCS.
At the appropriate time apoptosis was quan-
tified by inverted fluorescence microscopy after
addition of acridine orange to previously
undisturbed wells. The total number of normal
and apoptotic cells was determined in each of
three random high power fields (×100) from
the centre of each well and duplicate wells were
examined for each culture condition at each
time point. Thus the mean rate of apoptosis for
each individual experiment is based on six
observations and the results presented are the
mean of 3–5 independent experiments. Apop-
totic cells were identified by their shrunken,
absent, or budding cytoplasm, condensed bud-
ding and fragmenting nuclei, and fluorescence
enhancement by condensed chromatin, as
described previously.5 12 Cells were counted
first on the adherent monolayer and then in the
supernatant above each field to include any
detached apoptotic cells. To confirm that the
cells rounding up on the surface of the mono-
layer were apoptotic, the loosely adherent cells
from representative wells were harvested by
gentle washing and a cytospin preparation was
made and stained as previously described.5 In
addition, further preparations of the loosely
adherent condensed cells were washed and
harvested by centrifugation. The cellular DNA
was extracted from the resulting pellet and
subjected to analysis by electrophoresis, as
described by Baker and colleagues,12 to provide
confirmatory evidence of apoptosis. To further
validate the acridine orange staining method of
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quantifying apoptosis and to confirm the anti-
apoptotic aVect of IGF-1, further parallel
studies were undertaken. In these experiments,
apoptosis was quantified using FACS analysis
after staining with an anti-single stranded
DNA antibody (Chemicon, Temecula, Califor-
nia, USA), propidium iodide staining, and
annexin V binding (Calbiochem, Nottingham,
UK) according to the manufacturer’s instruc-
tions. In addition, caspase 3 activity was deter-
mined in cytosolic extracts from HSCs from
parallel experiments using the CaspACE assay
system according to the manufacturers’ in-
structions (Promega, Chilworth, UK).
EFFECT OF SOLUBLE GROWTH FACTORS ON
3
H-THYMIDINE INCORPORATION BY HSC
To examine the eVects of absolute serum dep-
rivation and exogenous growth factors on
DNA synthesis under conditions identical to
those used to quantify apoptosis, [methyl-3H]-
thymidine ([3H]-TdR) incorporation was
determined. Passaged cells grown in 24 well
plates were washed three times in serum free
media as described. Cultures were then incu-
bated in serum free DMEM with 0.1% bovine
serum albumin alone, or supplemented with
PDGF-AB (10 ng/ml), IGF-1 (10 ng/ml), or
TGF-â1 (10 ng/ml) for 19 hours. At this time
0.5 µCi [3H]-TdR (925 GBq/mmol) was added
to each well as 0.5 µl [3H]-TdR in 10 µl of
serum free DMEM. Cultures were then
incubated for a further five hours. After
incubation, [3H]-TdR incorporation was deter-
mined by scintillation counting of the cell layer
as previously described.13
EFFECT OF GROWTH FACTORS ON CELL NUMBERS
To determine the net eVect of growth factor
manipulation on overall HSC numbers, which
is a function of both cell proliferation and cell
death, genomic DNA content of cell monolay-
ers was quantified by Picogreen staining
(Molecular Probes, Ireland). Passaged HSCs
were cultured in 12 well plates and exposed to
serum deprivation or growth factors in dupli-
cate in an identical manner to that described
above. After 24 hours of incubation, the media
Figure 1 Histological analysis at peak fibrosis, 21 days after bile duct ligation (BDL). Livers harvested from animals 21
days after BDL were stained with reticulin (A, ×10) and Sirius red (B, ×20). A highly distinct pattern of matrix and
collagen is apparent in the expanded portal tracts. This neomatrix extends in a septate manner into the parenchyma, in
places linking portal tracts, and beginning to distort the liver architecture. Histological analysis of animals 42 days after
biliary-jejunal anastomosis: following biliary-jejunal anastomosis there was a progressive diminution in the stainable
collagen and matrix both within the parenchyma and adjacent to the bile ducts. At 42 days post anastomosis, reticulin
staining (C, ×10) and Sirius red staining (D, ×10) demonstrated that considerable matrix remodelling had taken place
with a return to near normal patterns of collagen and matrix.
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was removed and adherent cells were harvested
by scraping into 150 µl of Tris EDTA (TE)
(pH 7.5). The resulting suspension was
sonicated for 15 minutes. Sonicated product
(100 µl) was then diluted 1:1 with TE and
mixed with 100 µl of Picogreen, prediluted
1:200 in TE. The reaction mixture was placed
in wells of a 96 well plate and incubated in
darkness for five minutes at room temperature.
Controls of Herring sperm DNA diluted from
0 to 3 µg/ml were simultaneously prepared and
analysed in parallel. The fluorescence of the
samples was measured with a Cytofluor II
Microwell fluorescence reader (PerSpectives
Biosytems, Framingham, Massachusetts,
USA) and DNA concentration of each sample
determined by reference to a standard curve
generated from analysis of the control DNA.
DETECTION OF Fas/FasL EXPRESSION BY HSC
HSCs have been demonstrated recently to
express both Fas and Fas ligand (FasL) and the
autocrine production of FasL has been sug-
gested as an apoptotic mechanism for activated
HSCs. We undertook ribonuclease protection
analysis for Fas and FasL on HSC RNA. Total
RNA was extracted from HSCs using the
RNeasy method (Qiagen, Crawley, UK) after
serum deprivation, with or without IGF-1 or
PDGF treatment. The ribonuclease protection
assay for Fas/FasL was undertaken as previ-
ously described.14 Riboprobes were transcribed
using the rAPO-1 multiprobe template (Am-
bion, Oxon, UK) according to the manufactur-
er’s instructions. The probe template con-
tained a GAPDH control to confirm equal
sample loading.
DATA ANALYSIS
Results are expressed as mean (SEM). Statisti-
cal analysis was performed using the Students’
t test (two tailed). Significance was assumed
when p<0.05.
Results
HISTOLOGY OF SPONTANEOUS RECOVERY FROM
BILE DUCT LIGATION
The histology of the results of BDL and recov-
ery from BDL induced fibrosis has been
described in detail in a previous report.9 The
result of Sirius red and reticulin staining
confirmed that the collagen fibrils, which
extended out from the expanded portal triads
after 21 days of BDL, became progressively
remodelled during the 42 days of recovery fol-
lowing biliary-jejunal anastomosis. At peak
fibrosis (21 days following BDL) there was a
highly distinct pattern of collagen apparent in
the portal triads. This surrounded the prolifer-
ating bile ductules and extended into the
parenchyma in places forming distinct septae
linking portal triads (fig 1A, B). During the 42
days of recovery following biliary-jejunal anas-
tomosis there was progressive diminution of
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Figure 2 Alpha smooth muscle actin (á-SMA) staining
of each liver sample was used to demonstrate activated
hepatic stellate cells (HSCs). A progressive diminution of
the number of positive cells was observed when fibrotic liver,
21 days after bile duct ligation (BDL), was compared with
liver samples harvested after biliary-jejunal anastomosis.
Representative examples are shown of á-SMA staining at
peak fibrosis (21 days after BDL) (A) and after 42 days
of biliary-jejunal anastomosis (B) (each at ×10). Activated
HSCs are observed within and around the periportal
neomatrix and around the developing fibrotic septae (A).
After 42 days of recovery, residual activated HSC are
present in the periportal region but are considerably
diminished in number. (C) Overall results of quantification
of numbers of activated HSC defined by á-SMA
expression. There is progressive diminution in activated
HSCs following biliary-jejunal anastomosis, but even after
42 days the number is still raised above that observed in
sham operated controls.
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stainable collagen. Even after seven days of
recovery the septae became less defined and
the matrix surrounding the bile ductules
diminished. This process continued until at 42
days there remained only remnants of collagen
and matrix in the portal triads (fig 1C, D).
There was no notable histological abnormality
or evidence of stainable collagen in any of the
sham operated control livers.
SPONTANEOUS RECOVERY FROM FIBROSIS IS
ASSOCIATED WITH A DECREASE IN NUMBERS OF
ACTIVATED HSC
Because á-SMA is expressed by activated
HSCs, immunostaining for this protein was
used to detect and quantify numbers of
activated HSCs.15 Fibrotic liver at 21 days was
demonstrated to contain á-SMA positive cells
in the region that had been previously demon-
strated to be strongly stained with Sirius red. In
addition, á-SMA positive cells were observed
extending into the parenchyma as well as
within and surrounding fibrotic bands (fig 2A).
In fibrotic liver 21 days after BDL there were
14.4 (0.23) á-SMA positive cells per high
power field. The number of á-SMA positive
cells then progressively decreased over the 42
days of recovery (fig 2B, 2C). At all times dur-
ing recovery, the distribution of á-SMA
positive cells was within and extending into the
parenchyma from the fibrotic bands and the
areas of fibrosis surrounding the expanded
portal triads. The numbers of á-SMA positive
cells in the sham operated control livers were
negligible (<0.5 per high power field).
HSC APOPTOSIS OCCURS DURING SPONTANEOUS
RECOVERY FROM BILIARY FIBROSIS
Liver sections were dual stained for TUNEL
and á-SMA. TUNEL positive condensed
nuclei in the distribution of the collagen fibrils,
demonstrated by Sirius red and reticulin stain-
ing, were demonstrated to be within the
á-SMA positive cells (fig 3). Moreover, there
was no evidence of necrosis in á-SMA positive
cells. These data strongly support the hypoth-
esis that HSC apoptosis is occurring during
spontaneous recovery from fibrosis. The rate of
apoptosis in non-parenchymal cells during
recovery from fibrosis was quantified by direct
cell counting of TUNEL positive nuclei. These
were counted only around collagen fibrils—
that is, in the regions demonstrated to have the
highest density of á-SMA positive cells, as
described above. At 21 days after BDL, there
were 0.45 (0.02) TUNEL positive nuclei per
high power field which increased after two days
of recovery before falling progressively to 0.08
(0.01) TUNEL positive nuclei per high power
field on day 42 (fig 4). There were negligible
numbers of TUNEL positive cells in the sham
operated control livers.
ACTIVATED HSC UNDERGO APOPTOSIS FOLLOWING
SERUM DEPRIVATION
Apoptosis in cultured HSCs was quantified in
vitro by staining with acridine orange and
counting under fluorescence (as demonstrated
in fig 5A). In addition, to confirm that these
condensed cells had undergone apoptosis, they
were harvested by gentle washing, prepared as
a cytospin, and Giemsa stained (fig 5B). DNA
was extracted from further preparations. The
Figure 3 Two examples of apoptotic hepatic stellate cells
(HSCs) demonstrated by dual terminal UDP-nick end
labelling (TUNEL) and á smooth muscle actin (á-SMA)
staining. Liver sections at two days after biliary-jejunal
anastomosis were dual stained with á-SMA and TUNEL.
Non-parenchymal TUNEL positive cell nuclei (red)
demonstrating the characteristic condensation and halo are
observed within the á-SMA positive cells (blue), indicating
that the apoptotic nuclei lie within activated HSCs (×40).
Figure 4 Quantification of non-parenchymal cell
apoptosis during recovery from bile duct ligation (BDL).
Terminal UDP-nick end labelling (TUNEL) positive
non-parenchymal cell apoptotic bodies in a distribution
consistent with activated hepatic stellate cells (HSCs) were
quantified as described in the methods both before and after
biliary-jejunal anastomosis. The results indicated that the
first two days following biliary reanastomosis are associated
with an increase in apoptosis, which coincides with the
observed diminution in activated HSCs.
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DNA thus obtained demonstrated the ladder-
ing that results from oligonucleosomal frag-
mentation and is considered to be characteris-
tic of apoptosis (fig 5C). By determining the
rate of apoptosis at predetermined times after
serum withdrawal, as described above, we
demonstrated that deprivation of growth fac-
tors was associated with a significant increase
in HSC apoptosis at 6, 24, and 72 hours (fig 6).
Cycloheximide has been reported to enhance
serum deprivation induced apoptosis in a vari-
ety of cell types,12 16 therefore a further experi-
ment was conducted in which 6.25–50 µM
cycloheximide was added to the serum free
media. Cycloheximide induced a concentra-
tion dependent increase in apoptosis compared
with serum withdrawal alone, which was maxi-
mally eVective at 50 µM (data not shown).
IGF-1 BUT NOT PDGF OR IGF-2 RESCUES HSCs
FROM APOPTOSIS INDUCED BY SERUM
DEPRIVATION
The eVect of serum withdrawal suggested that
growth factors were important regulators of
HSC apoptosis in culture. To explore this con-
cept further we undertook a series of experi-
ments to examine the eVect of the growth fac-
tors IGF-1, IGF-2, TGF-â1, and PDGF on
HSC apoptosis, as these are expressed during
fibrotic injury. Incubation of HSC with IGF-1
in serum free media in concentrations of
0.1–10 ng/ml for 24 hours was associated with
a modest but consistent dose dependent
reduction in apoptosis compared with parallel
cultures maintained serum deprived; similar
results were obtained after six hours of
exposure. This eVect was significant at 1 and
10 ng/ml (fig 7A). In parallel studies, the eVect
of IGF-1 (10 mg/ml) in reducing apoptosis
relative to serum free and serum free with
cycloheximide (50 µM) control cultures was
determined by caspase 3 activity. Relative to
controls, IGF-1 reduced caspase 3 activity by
22% in serum free conditions, and by 80% in
serum free conditions in the presence of 50 µM
cycloheximide. Further studies using quantita-
tive FACS analysis of IGF-1 treated HSCs
relative to serum free controls after staining
with an anti-single stranded DNA antibody,
annexin V binding assays, and propidium
iodide staining demonstrated a similar reduc-
tion in apoptosis relative to controls in the
presence of IGF-1 (data not shown). Incuba-
tion of HSCs with IGF-2 (0.125–12.5 ng/ml)
or PDGF (0.1–100 ng/ml) resulted in no
significant change in apoptosis (22.9 (3.6)% in
serum free controls v 20.7 (3.1)% in cells
incubated with 12.5 ng/ml IGF-2, n=3; and
Figure 5 Acridine orange staining illustrating normal and apoptotic activated hepatic stellate cells (HSCs). (A)
Representative fields from passaged HSC incubated for four days in media with 16% serum (left) and in serum free conditions
(right).Normal HSC have large pale nuclei and orange tinged cytoplasm (the result of RNA staining).Apoptotic HSC are
distinct with brightly condensed chromatin with shrunken or absent cytoplasm; two of several examples are arrowed.Apoptotic
cells lift oV from the monolayer, therefore to focus on these the monolayer falls below the plane of focus.Mitotic figures are also
identifiable with this method (left field).Giemsa stain of cytospin preparation of condensed HSC: after exposure to conditions of
absolute serum deprivation as described in the methods, the condensed rounded up cells on the monolayer surface, corresponding
to the cells counted after acridine orange staining,were harvested by gentle washing and prepared as a cytospin, before being
Giemsa stained.The cells demonstrated clear evidence of chromatin condensation and fragmentation, and blebbing; a
representative example is given in (B).DNA analysis of the condensed and rounded up cells was undertaken as described in
the methods and demonstrates the characteristic laddering associated with apoptosis (C).
Figure 6 EVect of prolonged serum deprivation on hepatic
stellate cell (HSC) apoptosis. Rat HSCs were washed three
times and incubated for 6, 24, and 96 hours in media with
no additives (0% fetal calf serum (FCS)) or returned to
media with 16% FCS.After incubation, the number of
apoptotic cells was counted and expressed as a percentage of
the total cell number per field (mean (SEM), n=7;
*p<0.05, **p<0.01 for 0% FCS v 16% FCS at the same
time point by paired t test).
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23.8 (3.5)% in serum free controls v 22.1
(3.1)% in cells incubated with 100 ng/ml
PDGF; n=4). Similar results were obtained
after six hours of exposure. The addition of
IGF-1 to HSCs incubated in serum free condi-
tions in the presence of cycloheximide also sig-
nificantly protected HSCs from apoptosis after
24 hours of incubation, although the concen-
tration of IGF-1 required to be significantly
eVective in this context was 100 ng/ml (fig 7B).
The addition of TGF-â1 (10 ng/ml) to serum
deprived HSC cultures resulted in a 40%
increase in apoptosis relative to serum deprived
controls (n=4) which was significant at concen-
trations of both 1 and 10 ng/ml; this eVect was
maximal at six hours of exposure (fig 7A).
IGF-1 INDUCES AN INCREASE IN HSC NUMBERS BY
PROMOTING SURVIVAL
To determine the eVect on HSC proliferation
and number when cultures were incubated
with specific growth factors, further experi-
ments were undertaken in which HSC were
exposed to IGF-1 or PDGF for 24 hours and
the rate of proliferation and DNA concentra-
tion (as an index of overall cell numbers) were
determined. As previously anticipated, both
serum and PDGF were eVective mitogens (fig
8A). In contrast, IGF-1 was not mitogenic.
Indeed, there was no significant diVerence in
the rate of proliferation observed with PDGF
compared with serum, whereas proliferation
was significantly reduced after incubation with
IGF-1 compared with serum (fig 8A). When
total DNA concentration was analysed in par-
allel wells to act as an indicator of changes in
cell numbers, in comparison with cultures
maintained in serum free conditions alone,
FCS induced the greatest increase in cell num-
bers (fig 8B). IGF-1 induced a similar increase
in cell number. However, the increase in cell
number observed with PDGF was minor in
comparison with serum or IGF-1. These data
suggest that inhibition of apoptosis is a major
contributor to the increase in HSCs in culture
models. Incubation of HSCs with TGF-â1
resulted in a reduction in proliferation (fig 8C)
and a 30% decrease in total DNA content
reflecting a net decrease in HSC numbers rela-
tive to serum deprived controls (fig 8D).
RIBONUCLEASE PROTECTION ASSAY DETECTION
OF Fas/FasL
There was no diVerence in FasL mRNA
expression relative to GAPDH in cultures
maintained for 24 hours serum free, or treated
with IGF-1 (10 ng/ml) or PDGF (10 ng/ml). In
the same assays, Fas mRNA was not detected
(n=2; data not shown).
Discussion
The data presented in this paper demonstrate
evidence of the critical role of HSC apoptosis
in the spontaneous recovery from liver fibrosis.
By showing that HSC numbers decrease
during recovery and by providing clear evi-
dence of HSC apoptosis in a model which is
mechanistically distinct from that described in
our previous report,5 we conclude that HSC
apoptosis is a vital mechanism that contributes
to recovery from hepatic fibrosis regardless of
aetiology. Moreover, as we have previously dis-
cussed, there are clear paradigms of these
observations in the form of case reports of
human fibrotic disease in vivo.17 18
á Smooth muscle actin, an intermediate fila-
ment protein that is expressed by activated
HSC and is widely accepted to be a marker of
activation, was used to identify and quantify
activated HSCs. By staining the BDL liver
Figure 7 (A) EVect of specific growth factors on hepatic
stellate cell (HSC) apoptosis. EVect of insulin-like growth
factor 1 (IGF-1) and transforming growth factor â1
(TGF-â1) on serum deprivation induced apoptosis of rat
HSCs. For each concentration of growth factor (x axis,
ng/ml) the percentage of cells demonstrating an apoptotic
morphology after staining with acridine orange is expressed
as mean (SEM). For the IGF-1 experiments, counting was
undertaken after 24 hours (n=5, *p<0.05 v no additives
by paired t test). For the TGF-â1 experiments, counting was
undertaken after six hours (***p<0.001 by paired t test,
n=4). †S, serum containing media. (B) EVects of IGF-1
on cycloheximide induced apoptosis of rat HSCs.Washed
rat HSC cultures were incubated for six hours in media
with no additives, or media supplemented with 50 µM
cycloheximide (CHX) with or without IGF-1. The
percentage of cells undergoing apoptosis detected by acridine
orange staining is given as mean (SEM) (n=4). *p<0.05
for IGF-1 treated cultures v cycloheximide alone by paired t
test. SF, serum free.
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before and after reanastomosis we demon-
strated that the high numbers of activated
HSCs present at peak fibrosis rapidly dimin-
ished while remodelling of the fibrosis occurred
and a more normal architecture was restored.
Indeed, during the first week following reanas-
tomosis there was a fivefold diminution in acti-
vated HSC numbers. The diminution of HSCs
was not associated with an increase in inflam-
matory activity and specifically there was no
evidence of necrosis, and therefore we tried to
establish if there was evidence to indicate that
the HSC loss was mediated by apoptosis.
In our initial studies, dual staining of
representative samples of BDL liver which had
undergone reanastomosis with TUNEL and
á-SMA consistently demonstrated morpho-
logically apoptotic, TUNEL positive nuclei
within á-SMA positive cells, providing strong
evidence for the presence of HSC apoptosis.
We therefore established a series of experi-
ments to quantify HSC apoptosis following
BDL induced fibrosis and biliary reanastomo-
sis. As before,5 we undertook TUNEL staining
and á-SMA staining independently on sequen-
tial liver sections as this method allows optimal
conditions to be used for each stain. We then
applied strict morphological criteria to the
quantification of TUNEL positive apoptotic
bodies. Only those apoptotic bodies which
were TUNEL positive and lay within the areas
of fibrosis in the expanded portal triad were
counted. Reference to sections stained in
parallel for á-SMA indicated that the cells in
these areas were largely activated HSCs. The
results indicate that there is a background rate
of apoptosis in fibrotic livers 21 days after
BDL; these represent between 1% and 3% of
the á-SMA positive HSC population. Follow-
ing reanastomosis there is a clear increase in
the rate of apoptosis over 48 hours. Although
the absolute number of apoptotic figures
remains small and never represents at maxi-
mum more than 8% of the total HSC popula-
tion, an increase in the rate of apoptosis,
particularly in association with either a con-
stant rate of HSC proliferation or a reduction
in HSC proliferation, was associated with a
dramatic overall reduction in HSC numbers in
the liver. As the total time for apoptosis to
eliminate a single cell may be as little as 20
minutes,12 these results also serve to emphasise
that the HSC pool is dynamic and overall
numbers reflect changes in the rate of apopto-
sis in addition to representing changes in the
rate of proliferation, a feature emphasised in
our cell culture studies. Interestingly, the chro-
nology of HSC apoptosis diVers from that
observed in biliary epithelial cells during BDL
recovery, suggesting cell specificity in response
to individual survival signals.9
We had previously proposed that apoptosis
might be a default pathway for activated HSCs
unless specifically signalled to survive by physi-
cal (matrix) or soluble (cytokine and growth
factor) agents. To investigate this hypothesis
Figure 8 (A) EVect of growth factors on 3H-thymidine incorporation. After washing, rat hepatic stellate cells (HSCs)
were cultured in DMEM with no additives (serum free (SF)), 16% fetal calf serum (FCS) (+S, positive control), or
specified growth factors for 24 hours, and the rate of 3H-thymidine incorporated was determined as described. Results are
expressed relative to control cultures (no additives, SF) which were given the arbitrary value of 100% (n=4, *p<0.05
relative to 16% FCS containing cultures by paired t test). (B) EVect of growth factors on total DNA of cultures of rat
HSCs.Washed cultures of rat HSCs were incubated for 24 hours in DMEM with no additives (SF) or supplemented with
16% FCS (+S, positive control) or growth factors as shown and the total DNA concentration of each cell suspension was
determined as described in the methods. Results are expressed relative to control cultures (no additives, SF) which were
given the arbitrary value of 100% (n=4, *p<0.05 relative to 16% FCS containing cultures by paired t test). (C,D) EVect
of transforming growth factor â1 (TGF-â1) on HSC proliferation and total DNA content, respectively, were analysed as
described and are represented relative to control cultures (no additives, SF) which have been given the arbitrary value of
100%.
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and to complement our studies of the in vivo
recovery models we have undertaken a detailed
characterisation of the response of HSCs to
serum deprivation in the presence and absence
of specific growth factors.
Apoptosis was quantified in vitro by direct
cell counting under fluorescence illumination
after acridine orange staining. We and others
have consistently demonstrated that in fibro-
blast, HSC, and myofibroblast cultures, the
rounded up condensed cells on the monolayer
surface demonstrate features of apoptosis mor-
phologically and demonstrate the specific
nuclear changes of apoptosis.5 12 19 To further
validate this technique we have harvested the
condensed cells from the monolayer surface
and showed that the DNA demonstrates the
laddered pattern that results from oligonucleo-
somal fragmentation which is characteristic of
apoptosis.19 20 In further experiments we used
caspase activity assays and quantitative FACS
analysis after annexin V binding and propid-
ium iodide staining to confirm the increase in
apoptosis seen in serum deprivation.
Acridine orange staining demonstrated that
absolute serum deprivation increased the rate
of apoptosis above that observed in HSC in
serum containing media, supporting the hy-
pothesis that specific growth factors may
promote HSC survival. However, even in con-
ditions of absolute serum deprivation for up to
three days, the absolute level of apoptosis never
rose above 25% for HSCs 72 hours post
passage or 50% for cells 24 hours post passage.
This suggests that other influences, stage of the
cell cycle, cell-matrix and cell-cell interactions,
autocrine factors, or combinations of these
may also influence HSC survival in this model.
Moreover, mitotic figures were observed in the
serum deprived cultures indicating that this
treatment did not halt cell proliferation in
highly activated HSCs. Therefore, a possible
explanation for the relatively constant rate of
apoptosis after serum deprivation is that cells
have to be entering the growth cycle to be sus-
ceptible to apoptosis. Incubation with cy-
cloheximide has been reported to increase
apoptosis in a variety of cell types12 16 and was
associated with a concentration dependent
increase in HSC apoptosis which reached
100% after 24 hours in 50 µM cycloheximide.
Both IGF-1 and PDGF have been reported
to promote HSC growth; they and their
respective receptors are expressed by HSC.
During liver injury they may act in a paracrine
(from hepatocytes and KupVer/infiltrating in-
flammatory cells, respectively) and an auto-
crine manner.21–23 We therefore incubated
HSCs in the presence of increasing concentra-
tions of these growth factors in the absence of
serum. Our results demonstrate that IGF-1 but
not PDGF promotes HSC survival. Incubation
of HSC with IGF-1 was associated with a
highly reproducible although modest reduction
in apoptosis in concentrations of 10 and
1 ng/ml. In contrast, PDGF had no consistent
eVect on apoptosis. IGF-1 also proved to eVec-
tively inhibit apoptosis in the presence of
cycloheximide although a higher concentration
(100 ng/ml) was required to achieve this eVect
than with cultures in serum free media alone.
Taken together these data suggest that IGF-1 is
a candidate mediator promoting HSC survival
during injury, an eVect which has been
documented in a series of cell systems.24–27 It
also provides a mechanism in wounding in
which the epithelium (hepatocyte) may directly
regulate the survival of the wound healing
myofibroblast (HSC) in a paracrine man-
ner.21 28 While maximum inhibition of apopto-
sis of 20% induced by IGF-1 appears small, it
has been suggested that IGF-1 mediated
inhibition of apoptosis is somewhat underesti-
mated by in vitro work because more profound
eVects have been observed in experimental
manipulations in vivo.26 27 In contrast with
IGF-1, TGF-â1 actually increased apoptosis.
As TGF-â1 is a powerful profibrogenic stimu-
lus to HSCs, this observation suggests that the
same cytokine may simultaneously limit the
survival of matrix sythesising HSCs.
Expression of Fas and FasL has recently
been demonstrated in HSCs.6 29 FasL mRNA
was not regulated by either IGF-1 or PDGF
exposure when assayed by ribonuclease protec-
tion, and Fas mRNA was not detectable using
this method. This may suggest that the anti-
apoptotic eVect of IGF-1 was not due to a
decrease in FasL (a proapoptotic ligand) but by
some other, as yet, unidentified mechanism. In
our model, as in the previous FasL mediated
model reporter by Gong and colleagues,29
cycloheximide appears to promote HSC apop-
tosis. One possible explanation is that inhibi-
tion of a critical autocrine or intracellular sur-
vival factor is necessary to prime highly
activated HSCs for apoptosis through growth
factor withdrawal or TNF receptor superfamily
(Fas and related receptors) stimulation.
As the overall cell number in a tissue reflects
the net eVect of proliferation in addition to
apoptosis/death, we determined the impact of
our manipulations of culture conditions on
proliferation and total HSC number. In these
studies experiments were performed in an
identical manner to those in which apoptosis
was quantified and without cell cycle coordina-
tion. The 4.8-fold increase in 3H-thymidine
seen with PDGF is consistent with the well
described mitogenic eVects of this cytokine28
and contrast markedly with the lack of eVect on
apoptosis. Exactly the converse was observed
with IGF-1; a marginal eVect on proliferation
was observed (1.2-fold increase) in contrast
with the significant eVect on apoptosis. Viewed
with the data on total DNA, where incubation
with IGF-1 was associated with a 38%
increase, these results emphasise the
importance of survival as a mechanism to pro-
mote an overall increase in HSC numbers.
Compared with cultures returned to serum
containing media, all serum free experimental
conditions showed a reduction in cell number,
as determined by DNA concentration. Cul-
tures supplemented with PDGF contained a
similar number of cells suggesting that cell loss
must have occurred simultaneously and rein-
forcing the observation that the number within
the HSC pool is a dynamic function of
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proliferation and apoptosis. In fact there is evi-
dence that PDGF is proapoptotic for fibro-
blasts in conditions of low serum.30 In physi-
ological terms it is logical to propose that such
a potent inducer of proliferation should not
concurrently inhibit apoptosis—this combina-
tion of events is a classical feature of tumori-
genesis. Rather, that HSC proliferation and
apoptosis are independently controlled and
that the net cell number reflects the overall bal-
ance of these cell fates.
We have described HSC apoptosis in the
spontaneous recovery from BDL induced
hepatic fibrosis. These data together with our
previous report provide strong evidence for the
critical role of apoptosis of HSCs in spontane-
ous recovery from liver fibrosis. We have also
demonstrated that IGF-1 is a potent inhibitor
of HSC apoptosis in vitro and may function in
disease to regulate the increase in the pool of
activated HSC. In contrast, PDGF promotes
proliferation but is neutral with respect to HSC
apoptosis while TGF-â1 was observed to
increase apoptosis. These data are consistent
with a model in which HSC apoptosis results
from changes in the balance of pro and anti-
apoptotic influences which impinge on the cell
and are regulated independently of prolifera-
tive influences.
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